Georgia's Online Cancer Information Center

Winship realigns its research programs to increase impact

1/06/2020, The Cancer Letter

Winship Cancer Institute of Emory University has been granted formal approval from NCI to realign the four research programs funded by its NCI Cancer Center Support Grant. The realignment creates a new Cancer Immunology Research Program, which builds on Winship’s growing strengths in cancer immunology and the integration of immunology research ef forts across Emory University. “This realignment will open up more collaborative possibilities for our faculty and focus our ef forts on research that advances cancer discoveries,” said Kimberly F. Kerstann, Winship senior director for research administration. Madhav Dhodapkar, who joined in 2018 as inaugural director of the Winship Center for Cancer Immunology, and Rafi Ahmed, director of the Emory Vaccine Center, will lead this new program. The program will include translational physicians and scientists at Winship as well as from the Emory Vaccine Center and the Department of Immunology and Microbiology. The realignment also creates another entity, the Cell and Molecular Biology Research Program, led by Jing Chen, and Wei Zhou. The research themes for the CMB program are cancer cell metabolism, cancer cell stress and survival, mechanisms of invasion and metastasis, and gene regulation. Members of the former Cancer Cell Biology and Cancer Genetics and Epigenetics programs will migrate to the new CI and CMB programs. The other two Winship research programs will continue under the same names: Discovery and Developmental Therapeutics Research Program, led by Haian Fu, and Taofeek Owonikoko; and the Cancer Prevention and Control Research Program, led by Timothy L. Lash, and Mylin Torres. The benefit to patients will be significant because these research programs go to the core of how scientific discovery advances the prevention, detection, and treatment of cancer.

Media, News & Events

2021 Atlanta Precision Oncology Symposium

This one-day continuing education program will focus on current approaches to integrating and applying precision medicine into managing patients with breast, lung and genitourinary malignancies.


 Media & Events

Georgia Tech’s Durham picked to lead cancer organization

Lynn Durham has been named the new president and CEO of Georgia CORE. Durham, currently Georgia Tech vice president for institute relations, will replace Nancy Paris, who has led Georgia CORE since its inception and is retiring.



Lung Cancer Screening During the COVID-19 Pandemic

GASCO encourages all our members and members of the survivorship community to view the new video produced by the Medical Association of Georgia as the November offering of their "Top Docs" program.


 Screening & Genetics

Nancy Paris elevates cancer treatment and research in Georgia

Nancy Paris has served as president and CEO of Georgia CORE since its creation in 2005. At the end of the year, she will be retiring after spending her entire career in healthcare, during which she focused on addressing community health issues including homelessness, HIV/AIDS and rural health.


How the Georgia Sewers came to the rescue

Nearly 400 volunteers in 58 counties have been cutting out fabric and elastic, handling administrative duties and of course, sewing.


Georgia CORE and partners win five-year grant for colorectal cancer prevention

The CDC-funded program will bring colorectal screening, navigation and colonoscopies to 15,000 people in southeast and southwest Georgia.


Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now
Georgia CORE


Advancing Cancer Care through Partnerships and Innovation

Georgia CORE is a public-private partnership that creates collaboration among the state’s cancer organizations and institutions to connect more Georgians to quality, personalized cancer care. We welcome you to this one-of-a-kind online information center for all things related to cancer and survivorship care in Georgia.